Tokyo, March 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060864) titled 'Effect of Antipsychotic Medication on Remimazolam Sedation During Gastrointestinal Endoscopy' on March 9.
Study Type:
Observational
Primary Sponsor:
Institute - Asakayama general hospital
Condition:
Condition - Sedation during gastrointestinal endoscopy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to evaluate the effectiveness and safety of remimazolam sedation in patients receiving antipsychotic medications undergoing gastrointestinal endoscopy.
We will compare sedation success rate, total dose of remimazolam, and incidence of adve...